Physician profile
Eric B Smith
NPI 1033138102
$3,155.89
in general payments reported to CMS, 2019-2025
36 companies · $613 in 2025
The $613 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $333 · 2020: $164 · 2021: $424 · 2022: $496 · 2023: $371 · 2024: $755 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,739.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,043.66 | 2019-2025 | Xtandi, Myrbetriq |
| Boston Scientific Corporation | $217.58 | 2019-2023 | Spaceoar Vue System - 10ml |
| Novartis Pharmaceuticals Corporation | $212.10 | 2023-2025 | |
| Janssen Biotech, INC. | $203.00 | 2019-2025 | Erleada, Stelara |
| Bayer Healthcare Pharmaceuticals INC. | $129.53 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $125.29 | 2019-2025 | Provenge |
| Olympus America INC. | $117.46 | 2023-2025 | Itind System |
| Pfizer INC. | $98.07 | 2020-2025 | |
| Urogen Pharma, INC. | $74.91 | 2023-2024 | Jelmyto |
| Innovation Technologies INC | $72.14 | 2024-2025 | Irrisept |
| Ferring Pharmaceuticals INC. | $71.44 | 2024 | Adstiladrin |
| Antares Pharma, INC. | $64.77 | 2019-2020 | |
| Agiliti Surgical, INC. | $63.90 | 2021 | |
| Myovant Sciences INC. | $61.35 | 2021-2022 | |
| Medtronic, INC. | $51.55 | 2023-2025 | Ligasure, Signia |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $44.63 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $41.04 | 2024 | Xiaflex, Aveed |
| Axonics, INC. | $38.60 | 2022-2023 | Axonics |
| Intuitive Surgical, INC. | $36.00 | 2022 | |
| Immunitybio, INC. | $35.26 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $31.88 | 2024 | |
| Verity Pharmaceuticals INC. | $29.49 | 2024 | Trelstar |
| Siemens Medical Solutions USA, INC. | $28.96 | 2024-2025 | Ysio X.Pree, Acuson Sequoia Diagnostic Ultrasound System |
| Tempus Ai, INC | $28.61 | 2025 | Xt Cdx |
| Merck Sharp & Dohme LLC | $27.37 | 2025 | Lynparza |
| Civco Medical Instruments | $25.25 | 2024 | |
| Sun Pharmaceutical Industries INC. | $25.06 | 2022 | |
| Telix Pharmaceuticals | $24.90 | 2024 | Illuccix |
| Endo USA, INC. | $21.87 | 2024 | Xiaflex, Aveed |
| Cook Medical LLC | $20.35 | 2024 | Resonance |
| Ambu INC. | $20.20 | 2023 | |
| Bioprotect Medical, INC. | $17.73 | 2024 | Bioprotect Balloon Implant System |
| Coloplast Corp | $17.48 | 2022 | |
| Covidien Lp | $15.92 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $15.48 | 2019 | |
| Mission Pharmacal Company | $3.06 | 2024 | Uribel Tabs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.